The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading and Coronavirus Update

16 Apr 2020 07:00

RNS Number : 8043J
DX (Group) PLC
16 April 2020
 

16 April 2020

AIM: DX.

DX (Group) plc

("DX" or "the Group" or "the Company")

A leading provider of delivery solutions,

including parcel freight, secure, courier and logistics services

 

Trading and Coronavirus Update

 

DX, the provider of delivery solutions, including parcel freight, secure, courier and logistics services, announces an update on trading and the impact of the coronavirus pandemic on the business.

 

The Company's priority remains the welfare of employees, customers and the wider communities in which the Group operates. In line with UK Government guidelines, both the Company's divisions, DX Express and DX Freight, are designated as "essential service providers" and have continued to operate during the current 'lockdown' period. However, delivery procedures have been modified in line with the Public Health England guidelines to ensure social distancing and Government guidance will continue to be monitored.

 

Trading and Market Guidance

 

Trading between 3 March 2020, when the interim results were issued, and 21 March 2020, just prior to the Government's 'lockdown' measures to contain the spread of coronavirus, was in line with management's expectations. However, there was a reduction in overall delivery activity in the weeks immediately following the lockdown announcement of around 33% with this reduction varying across the different services. More recently, activity levels have shown improvement, and management has also re-allocated resources, where appropriate, towards the demand for more B2C deliveries and other initiatives.

 

The Board expects the reduction to significantly impact results for the current financial year ended 27 June 2020. As the duration and extent of the necessary measures to manage the coronavirus crisis are currently unknown, it is difficult to predict the full impact of the coronavirus crisis on the business. The Company will provide further updates on trading when the position becomes clearer.

 

Financial Position and Management Actions

 

The Board believes that the Company has the operational and financial capacity to navigate this challenging period. It has taken mitigating actions to conserve cash, reduce costs, and manage the Group through the crisis as prudently as possible. These measures will result in ongoing cost savings of approximately £21m in Q4 FY20. As operations return to more normal levels, these costs will be re-introduced in a managed, phased process. Approximately £10m of cash payments due to date and to be paid in the balance of Q4 FY20, have been deferred for up to 12 months. Net debt at the end of March was £8.9m, below the normal seasonal peak of £10-12m. It should be noted that this position is before the benefit of a number of large annual Document Exchange renewals due on 1 April.

 

The Group has a £20 million invoice discount facility available to it. Based on the current cash position, mitigating actions taken, and the forecast cash requirements, which take into account the current reduced level of activity, management believes that the Company has a satisfactory level of headroom through this period of disruption to trading. In addition, DX's funding bank remains supportive.

 

Swift and decisive actions taken include reducing the amount of temporary labour and spot hire vehicles used across the Group, and furloughing employees from those areas that are experiencing a reduced level of business. Other measures are in place, including utilising government assistance programmes, HMRC initiatives and payment holidays with vehicle providers. The Board has also re-evaluated capital expenditure plans and cut capex spending, proceeding only with a limited number of committed projects. In addition, all Board Directors and members of the senior management team have agreed to a reduction of 20% in salaries and fees with effect from 1 May 2020 until further notice.

 

Ronald Series, Chairman, commented:

 

"Our top priority remains the welfare of our staff and customers, and we would like to thank all our staff for their tremendous response during this difficult time.

 

"While the coronavirus crisis has impacted the business, we believe that the Group has sufficient financial capacity, and the operational expertise and management to weather this disruption and the ongoing uncertainty. We have taken swift and decisive action, and have implemented sensible measures to conserve cash and reduce costs to support the Group's position.

 

"We remain very well-positioned to continue to support all our customers and to contribute to the important services provided to Her Majesty's Government and to the National Health Service."

 

 

Enquiries:

 

DX (Group) plc

T: 020 3178 6378 (c/o KTZ

Ronald Series, Chairman

 Communications)

Lloyd Dunn, Chief Executive Officer

David Mulligan, Chief Financial Officer

finnCap (Nominated Adviser and Joint Broker to DX)

T: 020 7220 0500

Matt Goode/Simon Hicks/Hannah Boros (Corporate Finance)

Andrew Burdis/Camille Gochez (ECM)

Liberum (Joint Broker to DX)

T: 020 3100 2000

Robert Morton/Euan Brown/Laura Hamilton

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis

Dan Mahoney

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFFTSRIELII
Date   Source Headline
26th Oct 202012:36 pmRNSDirector Share Purchase
21st Oct 20207:00 amRNSDX Expands Depot Network with New Burnley Site
19th Oct 20208:50 amRNSNotice of AGM and Annual Report and Accounts
16th Oct 202012:23 pmRNSHolding(s) in Company
14th Oct 20203:05 pmRNSAppointment of Auditor
29th Sep 20207:00 amRNSDirector Share Purchase
28th Sep 20208:23 amRNSDirector Share Purchase
21st Sep 202012:08 pmRNSDirector Share Purchase
18th Sep 202011:24 amRNSDirector Share Purchase - Replacement
17th Sep 20204:31 pmRNSDirector Share Purchase
17th Sep 20207:00 amRNSPreliminary Results
10th Sep 20207:50 amRNSExpands depot network with two new sites
14th Jul 20207:00 amRNSTrading Update
9th Jul 20207:00 amRNSJoins consortium to deliver COVID-19 testing kits
3rd Jul 20204:36 pmRNSHolding(s) in Company
2nd Jul 20202:06 pmRNSSecond Price Monitoring Extn
2nd Jul 20202:00 pmRNSPrice Monitoring Extension
2nd Jul 20208:00 amRNSPDMR Share Purchase
1st Jul 202011:35 amRNSDirector Share Purchase
30th Jun 20204:17 pmRNSDirector Share Purchase
29th Jun 20209:06 amRNSDirector Share Purchase
15th Jun 20207:00 amRNSDirector Share Purchase
8th Jun 20207:00 amRNSLaunching an Expanded DX Express Centre in Ipswich
5th Jun 20207:00 amRNSDirector Share Purchase
29th May 202012:11 pmRNSDirector/PDMR Shareholding
28th May 20204:07 pmRNSCompany Secretary Share Purchase
28th May 20207:00 amRNSTrading Update
27th Apr 202010:27 amRNSDirector Share Purchase
17th Apr 20202:15 pmRNSDirector Share Purchase
16th Apr 20207:00 amRNSTrading and Coronavirus Update
1st Apr 20207:00 amRNSHolding(s) in Company
23rd Mar 20207:00 amRNSDirector/PDMR Shareholding
19th Mar 20207:00 amRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSAppointment of Joint Broker
3rd Mar 20207:00 amRNSInterim Results
24th Feb 20207:00 amRNSNotice of Interim Results
4th Feb 20207:00 amRNSTrading update
3rd Jan 202012:40 pmRNSHolding(s) in Company
28th Nov 201912:38 pmRNSResult of AGM
28th Nov 20197:00 amRNSAGM Statement
15th Oct 201912:41 pmRNSReplacement: Notice of AGM
15th Oct 20198:06 amRNSNotice of AGM
24th Sep 20197:00 amRNSPreliminary Results
23rd Jul 20197:00 amRNSPre-close Trading Update
3rd Jul 20191:30 pmRNSDirector/PDMR Shareholding
29th May 20194:35 pmRNSPrice Monitoring Extension
28th May 20197:00 amRNSHMPO Contract and Trading Update
16th Apr 201912:41 pmRNSDirector/PDMR Shareholding
26th Mar 20195:52 pmRNSHolding(s) in Company
5th Mar 20197:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.